Tuoxin Pharmaceutical Group Co.,Ltd. engages in the research and development, production and sales of nucleoside (acid) APIs and pharmaceutical intermediates in China. The company offers nucleoside (acid) products, such as pyrimidine series, purine series, and nucleotide series; nucleoside series, including citicoline sodium, ribavirin, inosine, acyclovir, azithromycin, cytosine, 5-fluorocytosine, cytidine, uridine; and other APIs and pharmaceutical intermediates covering antiviral, anti-tumor, and nervous system. Tuoxin Pharmaceutical Group Co.,Ltd. was founded in 2001 and is based in Xinxiang, China.
Metrics to compare | 301089 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship301089PeersSector | |
---|---|---|---|---|
P/E Ratio | −171.1x | −16.9x | −0.5x | |
PEG Ratio | −2.86 | 0.02 | 0.00 | |
Price/Book | 2.8x | 3.4x | 2.6x | |
Price / LTM Sales | 10.6x | 4.2x | 3.3x | |
Upside (Analyst Target) | - | −0.5% | 43.4% | |
Fair Value Upside | Unlock | −7.2% | 7.1% | Unlock |